AzTrials
AzTrials

Periapical LesionNCT07246512

A Comparative Analysis of Biomaterials for Retrograde Filling in Apical Surgery.

A study testing Mineral Trioxide Aggregate and BioCeramic Root Repair Material Fast Set Putty. in people with Periapical Lesion, run by University of Valencia at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to compare two biomaterials used for retrograde obturation during apical surgery. This surgery is indicated in healthy patients when root canal treatment (endodontics) has failed to eliminate a periapical lesion (a persistent infection in the root of the tooth). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Periapical Lesion
What is being tested?
Mineral Trioxide Aggregate and BioCeramic Root Repair Material Fast Set Putty.
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteSpain
Study dates
8 Feb 2024to 20 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients over 18 years of age.
  • Patients giving consent for surgical intervention, for radiographic evaluation with HCT preoperatively and at least one more time after 12 months, and for participation in the study.
  • Medical history not relevant to the diagnosis and surgical treatment (ASA classes I and II).
  • Previous non-surgical endodontic treatment or retreatment with clinical and/or radiographic evidence of persistence or recurrence of apical periodontitis. The minimum time since the last non-surgical treatment shall be 6 months.
  • Teeth not previously treated with periapical surgery.
  • Lesion less than 10 mm in diameter.
Show all 9Show fewer
  • Restorable teeth.
  • Periodontally sound teeth or teeth with treated periodontal pathology (mobility 1, probing depth < 5mm).
  • Teeth with no root resorption.

Who cannot join

  • Teeth with vertical fracture.
  • Teeth with root perforation.
  • Lesions associated with an apicomarginal defect.
  • Tunnel lesions.
  • Technical errors during surgery that may compromise the outcome.
  • Lack of integrity of the dentine walls surrounding the retrograde filling detected with the endoscope.
Show all 9Show fewer
  • Wound dehiscence.
  • Postoperative infection.
  • Follow-up less than 12 months.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Valencia

    Valencia, 46010

Other trials in Spain

About this study

Official title: Comparison Between MTA and TotalFill® BC-RRM Fast Set Putty for Retrograde Filling in Apical Surgery: Randomized Non-inferiority Clinical Trial.

The aim of this study is to compare two biomaterials used for retrograde obturation during apical surgery. This surgery is indicated in healthy patients when root canal treatment (endodontics) has failed to eliminate a periapical lesion (a persistent infection in the root of the tooth).

The main question it seeks to answer is:

Read more
  • Is TotalFill® BC-RRM Fast Set Putty more effective than ProRoot® MTA in periapical surgery in terms of the degree of healing?

The study will include patients who need this type of surgery and meet specific clinical criteria. Each patient will have one of the two materials applied as part of the standard surgical procedure. Subsequently, clinical and radiographic follow-up will be performed to assess the degree of healing of the periapical lesion with a 1-year follow-up.

Being tested
Mineral Trioxide Aggregate, BioCeramic Root Repair Material Fast Set Putty.
Keywords
periapical lesion, endodontic failure, apical surgery, retrograde filling, periapical healing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mineral Trioxide AggregateDevice

    Also called MTA, ProRoot® MTA

    Trioxide Mineral Aggregate as a retrograde filling material has 3 basic properties: biocompatibility, impermeable sealing of the root canal and properties that facilitate its clinical use. It has excellent properties that contribute to the healing of the periapical lesion.

  • BioCeramic Root Repair Material Fast Set Putty.Device

    Also called BCRRM, TotalFill® BC-RRM Fast Set Putty

    BioCeramic Root Repair Material (BCRRM) is a pre-mixed, easy to handle material that has demonstrated properties equivalent to MTA in terms of periapical lesion healing.

Study groups in NCT07246512
Study groupRoleWhat they receive
MTA (Mineral Trioxide Aggregate)Active comparatorPatients undergoing apical surgery treated with retrograde obturation using Mineral Trioxide Aggregate (MTA).
Receives: Device: Mineral Trioxide Aggregate
BioCeramic Root Repair Material Fast Set Putty (BCRRM)ExperimentalPatients undergoing apical surgery treated with retrograde obturation using BioCeramic Root Repair Material Fast Set Putty (BCRRM).
Receives: Device: BioCeramic Root Repair Material Fast Set Putty.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Periapical lesion healing assessed by CBCT using 3D PENN criteria.

    Periapical healing will be evaluated using cone-beam computed tomography (CBCT) at 12 months after periapical surgery. Lesion volume or dimensions will be measured and the percentage of reduction will be calculated. Based on these measurements, healing will be classified according to the 3D PENN CBCT criteria into complete, limited, uncertain, or unsatisfactory healing. A comparison will be made between ProRoot® MTA versus TotalFill® BC-RRM Fast Set Putty as retrograde filling materials.

    Measured: 12 months post-surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2025
  2. Study start8 Feb 2024
  3. Primary completion20 Jan 2026
  4. Study completion20 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07246512
Sponsor's protocol ID
1. UV-INV_ETICA-1427893
Status last verified
Jul 2026
First submitted
17 Nov 2025
Last updated
13 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided: Considerations about sharing individual participant data are ongoing. Any future data sharing will adhere to all institutional policies to ensure participant confidentiality.

Questions about this trial

What is this clinical trial studying?

A study testing Mineral Trioxide Aggregate and BioCeramic Root Repair Material Fast Set Putty. in people with Periapical Lesion, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Periapical lesion healing assessed by CBCT using 3D PENN criteria. (time frame: 12 months post-surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in